T Bin Teni, N A Almutairi, S Abuhaimed, S Alaskar, G Alkhamis, B A Alsfouk, M R Almarzouqi, S Alageel, A Alsemari
OBJECTIVE: This study aimed to evaluate the efficacy and tolerability of perampanel, which was used in a cohort of patients with refractory epilepsy for up to 3.5 years in a real-world setting in Saudi Arabia. PATIENTS AND METHODS: Data from the medical records of patients treated with perampanel between March 13th, 2017, and September 6th, 2020, at neurology clinics at King Faisal Specialist Hospital and Research Centre (KFSHRC), Riyadh and Jeddah, Saudi Arabia, was collected...
March 2024: European Review for Medical and Pharmacological Sciences